Skip to content
Search

Latest Stories

Alex Potter is new MD at PharmAssist Solutions UK

Alex Potter is the new Managing Director of PharmAssist Solutions UK, an online purchasing solution utilised by over 1,100 community pharmacies. Potter, previously the Director of Digital at Phoenix UK, will succeed the current MD, Amar Randhawa, and has expertise in the digital landscape across the industry, PharmAssist Solutions said in a statement.

"We are delighted to have Alex on board," said Stuart Lucas, Chair of the PharmAssist Solutions Board. "His profound grasp of the pharmacy sector, combined with his expertise in digital innovation, will spearhead PharmAssist Solution's evolution to meet the dynamic demands of its clientele."


Meanwhile, Lucas expressed his gratitude and appreciation to Amar for his hard work and dedication over the last decade. "Amar, as the founder of PharmAssist Solutions, played a pivotal role in achieving numerous significant milestones and driving its growth," he added. "We wish him every success in his future endeavors."

"Alex’s profound expertise in the digital realm will undoubtedly propel PharmAssist Solutions to new heights," added Jeremy Main, Independent NED for PharmAssist Solutions. "This appointment builds on the impressive legacy left by Amar, fortifying our capacity to deliver a top-tier service in the pharmacy sector."

PharmAssist Solutions is dedicated to furnishing pharmacy teams with state-of-the-art software solutions that foster business development and growth, the statement added.

Last week, Titan PMR, a technology firm specialising in PMR systems for community pharmacies, introduced 'Titanverse'. This platform aims to redefine pharmacy management by offering comprehensive solutions that extend beyond prescription management, and takes a versatile approach, efficiently handling all facets of pharmacy operations, from high-level management down to daily tasks, according to the company.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less